Bionano Genomics, Inc. (BNGO) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $10K. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 4, 2026 | Luderer Albert Interim Chief Executive | +$4,845 | 4,000 | +100% | No | |
|
|
||||||
| Aug. 21, 2026 | Luderer Albert Interim Chief Executive | +$4,860 | 4,000 | New | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Adamchak Mark Principal Accounting Officer | $0 | 5,000 | 0% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Dixon Jonathan V. General Counsel | $0 | 15,000 | 0% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | OLDAKOWSKI MARK Chief Operating Officer | $0 | 15,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free